154 related articles for article (PubMed ID: 35668369)
1. An iron metabolism and immune related gene signature for the prediction of clinical outcome and molecular characteristics of triple-negative breast cancer.
Li XF; Fu WF; Zhang J; Song CG
BMC Cancer; 2022 Jun; 22(1):619. PubMed ID: 35668369
[TBL] [Abstract][Full Text] [Related]
2. A novel model associated with tumor microenvironment on predicting prognosis and immunotherapy in triple negative breast cancer.
Zhang J; Zhang M; Tian Q; Yang J
Clin Exp Med; 2023 Nov; 23(7):3867-3881. PubMed ID: 37219794
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of a ferroptosis-related signature for prediction of the prognosis and tumor microenvironment in patients with chromophobe renal cell carcinoma.
Liu S; Yao Y; Hou M; Mei J; Sun L; Zhang G
BMC Cancer; 2023 Nov; 23(1):1079. PubMed ID: 37940859
[TBL] [Abstract][Full Text] [Related]
4. Development and verification of a novel immunogenic cell death-related signature for predicting the prognosis and immune infiltration in triple-negative breast cancer.
Li J; Li Z; Yang W; Pan J; You H; Yang L; Zhang X
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2007. PubMed ID: 38425247
[TBL] [Abstract][Full Text] [Related]
5. A novel fatty-acid metabolism-based classification for triple negative breast cancer.
Yang X; Tang W; He Y; An H; Wang J
Aging (Albany NY); 2023 Feb; 15(4):1177-1198. PubMed ID: 36880837
[TBL] [Abstract][Full Text] [Related]
6. Identification of m6A modification patterns and development of m6A-hypoxia prognostic signature to characterize tumor microenvironment in triple-negative breast cancer.
Shen X; Zhong J; He J; Han J; Chen N
Front Immunol; 2022; 13():978092. PubMed ID: 36105819
[TBL] [Abstract][Full Text] [Related]
7. The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma.
Tang B; Zhu J; Li J; Fan K; Gao Y; Cheng S; Kong C; Zheng L; Wu F; Weng Q; Lu C; Ji J
Cell Commun Signal; 2020 Oct; 18(1):174. PubMed ID: 33115468
[TBL] [Abstract][Full Text] [Related]
8. Identification of TFR2 as a novel ferroptosis‑related gene that serves an important role in prognosis and progression of triple‑negative breast cancer.
Yang Y; Du J; Huang YF; He W; Liu L; Li D; Chen R
Oncol Lett; 2024 Feb; 27(2):43. PubMed ID: 38106522
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive characterization of stemness-related lncRNAs in triple-negative breast cancer identified a novel prognostic signature related to treatment outcomes, immune landscape analysis and therapeutic guidance: a silico analysis with in vivo experiments.
Zhang M; Zhang F; Wang J; Liang Q; Zhou W; Liu J
J Transl Med; 2024 May; 22(1):423. PubMed ID: 38704606
[TBL] [Abstract][Full Text] [Related]
10. Construction of iron metabolism-related prognostic features of gastric cancer based on RNA sequencing and TCGA database.
Liu X; Ren J; Zhou R; Wen Z; Wen Z; Chen Z; He S; Zhang H
BMC Cancer; 2023 Nov; 23(1):1106. PubMed ID: 37957566
[TBL] [Abstract][Full Text] [Related]
11. Novel molecular insights into pyroptosis in triple-negative breast cancer prognosis and immunotherapy.
Yu B; Luo J; Yang Y; Zhen K; Shen B
J Gene Med; 2024 Jan; 26(1):e3645. PubMed ID: 38041540
[TBL] [Abstract][Full Text] [Related]
12. Development of an ubiquitin-proteasome system signature for predicting prognosis and providing therapeutic guidance for patients with triple-negative breast cancer.
Chen X; Ren C; Zhou Z; Chen J; Fan X; Li X; Chen J; Zhu J
J Gene Med; 2024 Jan; 26(1):e3584. PubMed ID: 37605934
[TBL] [Abstract][Full Text] [Related]
13. Melanoma Molecular Subtypes and Development of Prognostic and Immunotherapy-Related Genetic Characteristics by Ferroptosis Gene Analysis.
Xu L; Zhang Y; Liu T; Wang L; Zhao Z; Zhang X; Li X; Wu W; Yu S
Comput Math Methods Med; 2022; 2022():2992939. PubMed ID: 35516454
[TBL] [Abstract][Full Text] [Related]
14. An exosome-based specific transcriptomic signature for profiling regulation patterns and modifying tumor immune microenvironment infiltration in triple-negative breast cancer.
Wang H; Wang R; Luo L; Hong J; Chen X; Shen K; Wang Y; Huang R; Wang Z
Front Immunol; 2023; 14():1295558. PubMed ID: 38124743
[TBL] [Abstract][Full Text] [Related]
15. Combined mRNAs and clinical factors model on predicting prognosis in patients with triple-negative breast cancer.
Hu Y; Zou D
PLoS One; 2021; 16(12):e0260811. PubMed ID: 34965257
[TBL] [Abstract][Full Text] [Related]
16. Identification of immune-related prognostic biomarkers in triple-negative breast cancer.
Song XQ; Shao ZM
Transl Cancer Res; 2024 Apr; 13(4):1707-1720. PubMed ID: 38737702
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel five ferroptosis-related gene signature as a promising prognostic model for breast cancer.
Cheng TC; Wu JH; Zhu B; Gao HY; Zheng L; Chen WX
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16779-16795. PubMed ID: 37728703
[TBL] [Abstract][Full Text] [Related]
18. Integrating iron metabolism-related gene signature to evaluate prognosis and immune infiltration in nasopharyngeal carcinoma.
Su J; Zhong G; Qin W; Zhou L; Ye J; Ye Y; Chen C; Liang P; Zhao W; Xiao X; Wen W; Luo W; Zhou X; Zhang Z; Cai Y; Li C
Discov Oncol; 2024 Apr; 15(1):112. PubMed ID: 38602575
[TBL] [Abstract][Full Text] [Related]
19. A risk model based on 10 ferroptosis regulators and markers established by LASSO-regularized linear Cox regression has a good prognostic value for ovarian cancer patients.
Xiong T; Wang Y; Zhu C
Diagn Pathol; 2024 Jan; 19(1):4. PubMed ID: 38178187
[TBL] [Abstract][Full Text] [Related]
20. Identification of a Gene Expression Signature to Predict the Risk of Early Recurrence and the Degree of Immune Cell Infiltration in Triple-negative Breast Cancer.
Sato K; Miura K; Tamori S; Akimoto K
Cancer Genomics Proteomics; 2024; 21(3):316-326. PubMed ID: 38670590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
